Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2022

Feb 3, 2022

30718_dirs_2022-02-03_2c2ed01a-c99c-43c1-883c-8092f0a7c3c3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2022-01-03

Reporting Person: Geist William (President, Protein Sciences)